Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia
Open Access
- 29 April 2022
- journal article
- case report
- Published by Frontiers Media SA in Pathology and Oncology Research
- Vol. 28, 1610338
Abstract
Hairy cell leukaemia (HCL) is a rare B cell malignancy with an indolent course leading to pancytopaenia due to bone marrow infiltration. It has been proposed that HCL patients are at risk of developing a secondary malignancy, with a marked likelihood of the development of other hematologic malignancies including Hodgkin lymphoma and high-grade non-Hodgkin lymphomas. Here, we present the case of two patients who developed diffuse large B cell lymphoma after a long course of hairy cell leukaemia. In the case of the female patient, we report on the occurrence of a third malignant disease, which is very uncommon. With our case descriptions we contribute to the very small number of similar cases reported.Keywords
Funding Information
- Horizon 2020
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
This publication has 18 references indexed in Scilit:
- Long‐term follow‐up and second malignancies in 487 patients with hairy cell leukaemiaBritish Journal of Haematology, 2014
- Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution seriesBlood, 2014
- Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 TrialClinical Lymphoma Myeloma and Leukemia, 2011
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- Second Cancer Incidence and Cause-Specific Mortality Among 3104 Patients With Hairy Cell Leukemia: A Population-Based StudyJNCI: Journal of the National Cancer Institute, 2007
- Long remissions in hairy cell leukemia with purine analogsCancer, 2005
- Transformation of hairy cell leukemia to high-grade lymphoma: A case report and review of the literatureHuman Pathology, 2004
- Second Malignancies as a Consequence of Nucleoside Analog Therapy for Chronic Lymphoid LeukemiasJournal of Clinical Oncology, 1999
- Second Malignancy in Hairy Cell Leukaemia: No Evidence of Increased Incidence After Treatment with Interferon AlphaLeukemia & Lymphoma, 1996
- Second cancer risk after interferon therapy?1994